Literature DB >> 9171327

Cerebellar pathology in sporadic and familial Alzheimer's disease including APP 717 (Val-->Ile) mutation cases: a morphometric investigation.

Y Fukutani1, N J Cairns, M N Rossor, P L Lantos.   

Abstract

Familial Alzheimer's disease (FAD) tends to present with more prominent neurological symptoms including cerebellar signs than sporadic Alzheimer's disease (SAD). In order to elucidate the pathological differences in the cerebellum, which may be associated with the cerebellar symptoms, we have investigated morphometrically beta-amyloid deposits, atrocytosis, Purkinje cells and dentate neurons in the cerebellum of 10 FAD patients including two cases with the beta-amyloid precursor protein (APP) gene mutation (APP717 Val-->Ile), 10 SAD patients and 10 non-demented age-matched controls. The regions examined included the molecular, Purkinje cell and granular cell layers, the cerebellar white matter and the dentate nucleus. Purkinje cell density in FAD was significantly lower than in SAD. There were no significant differences in the density of dentate neurons among the three groups. The density of astrocytes in FAD was significantly greater than that in SAD in the granular cell and Purkinje cell layers and in the white matter. There were no significant differences in the amount and subtypes of beta-amyloid deposits (extracellular, vascular and perivascular) between FAD and SAD in all the regions investigated. In two cases with the APP mutation, both Purkinje cell loss and beta-amyloid deposition in the cerebellum were greater than the mean for FAD and SAD cases. Astrocytosis in the mutation cases was not greater than the mean for FAD cases except for the dentate nucleus in one case. Extracellular beta-amyloid deposits were not seen in any of the control cases although amyloid angiopathy was observed in one case. This study demonstrates for the first time that Purkinje cell loss and reactive astrocytosis of the cerebellum in FAD are more severe than in SAD, but that beta-amyloid deposition in the cerebellum in both FAD and SAD are similar. The more prominent neurological signs observed in FAD may be explained by more severe neurodegeneration than are found in sporadic cases.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9171327     DOI: 10.1016/s0022-510x(97)05399-9

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  10 in total

1.  Neuroinflammatory Cytokines-The Common Thread in Alzheimer's Pathogenesis.

Authors:  W Sue T Griffin; Steven W Barger
Journal:  US Neurol       Date:  2010

2.  Loss of deep cerebellar nuclei neurons in the 3xTg-AD mice and protection by an anti-amyloid β antibody fragment.

Authors:  Gisela Esquerda-Canals; Joaquim Marti; Geovanny Rivera-Hernández; Lydia Giménez-Llort; Sandra Villegas
Journal:  MAbs       Date:  2013-06-20       Impact factor: 5.857

3.  Caspase-cleaved glial fibrillary acidic protein within cerebellar white matter of the Alzheimer's disease brain.

Authors:  Troy T Rohn; Lindsey W Catlin; Wayne W Poon
Journal:  Int J Clin Exp Pathol       Date:  2012-11-20

Review 4.  Correlating familial Alzheimer's disease gene mutations with clinical phenotype.

Authors:  Natalie S Ryan; Martin N Rossor
Journal:  Biomark Med       Date:  2010-02       Impact factor: 2.851

5.  Sparse temporally dynamic resting-state functional connectivity networks for early MCI identification.

Authors:  Chong-Yaw Wee; Sen Yang; Pew-Thian Yap; Dinggang Shen
Journal:  Brain Imaging Behav       Date:  2016-06       Impact factor: 3.978

Review 6.  Tau, prions and Aβ: the triad of neurodegeneration.

Authors:  Lilla Reiniger; Ana Lukic; Jacqueline Linehan; Peter Rudge; John Collinge; Simon Mead; Sebastian Brandner
Journal:  Acta Neuropathol       Date:  2010-05-16       Impact factor: 17.088

7.  Early limited nitrosamine exposures exacerbate high fat diet-mediated type 2 diabetes and neurodegeneration.

Authors:  Ming Tong; Lisa Longato; Suzanne M de la Monte
Journal:  BMC Endocr Disord       Date:  2010-03-19       Impact factor: 2.763

8.  Heavy Tau Burden with Subtle Amyloid β Accumulation in the Cerebral Cortex and Cerebellum in a Case of Familial Alzheimer's Disease with APP Osaka Mutation.

Authors:  Hiroyuki Shimada; Shinobu Minatani; Jun Takeuchi; Akitoshi Takeda; Joji Kawabe; Yasuhiro Wada; Aya Mawatari; Yasuyoshi Watanabe; Hitoshi Shimada; Makoto Higuchi; Tetsuya Suhara; Takami Tomiyama; Yoshiaki Itoh
Journal:  Int J Mol Sci       Date:  2020-06-22       Impact factor: 5.923

9.  The presubiculum is preserved from neurodegenerative changes in Alzheimer's disease.

Authors:  Christina E Murray; Priya Gami-Patel; Eleni Gkanatsiou; Gunnar Brinkmalm; Erik Portelius; Oliver Wirths; Wendy Heywood; Kaj Blennow; Jorge Ghiso; Janice L Holton; Kevin Mills; Henrik Zetterberg; Tamas Revesz; Tammaryn Lashley
Journal:  Acta Neuropathol Commun       Date:  2018-07-20       Impact factor: 7.801

10.  Cerebellar Calcium-Binding Protein and Neurotrophin Receptor Defects in Down Syndrome and Alzheimer's Disease.

Authors:  Jennifer C Miguel; Sylvia E Perez; Michael Malek-Ahmadi; Elliott J Mufson
Journal:  Front Aging Neurosci       Date:  2021-03-12       Impact factor: 5.750

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.